Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator
Hypha Labs (OTCQB:FUNI), a functional mushroom sciences company, has filed three new patents with the USPTO to protect its mushroom cultivation innovations. The patents include: 1) A Mushroom Accelerator System for mycelium cultivation using AI and cloud-based monitoring, 2) A Commercial Mushroom Accelerator System for large-scale production with modular cartridges, and 3) A Replaceable Sterile Cartridge System featuring AI-optimized growth processes. The company aims to implement a razor/razor blade business model through its cartridge system, targeting both home users and commercial kitchens.
The company has also enhanced its research capabilities with a new HPLC machine and variable loop autosampler upgrade to advance mushroom cultivation equipment and genetic research.Hypha Labs (OTCQB:FUNI), un'azienda specializzata nelle scienze dei funghi funzionali, ha depositato tre nuovi brevetti presso l'USPTO per proteggere le sue innovazioni nella coltivazione dei funghi. I brevetti comprendono: 1) un Sistema Acceleratore per Funghi per la coltivazione del micelio che utilizza l'IA e il monitoraggio basato su cloud, 2) un Sistema Acceleratore Commerciale per Funghi per la produzione su larga scala con cartucce modulari, e 3) un Sistema a Cartucce Sterili Sostituibili con processi di crescita ottimizzati dall'IA. L'azienda punta a implementare un modello di business simile a quello del rasoio e delle lame attraverso il suo sistema a cartucce, rivolgendosi sia agli utenti domestici sia alle cucine commerciali.
Inoltre, l'azienda ha potenziato le sue capacità di ricerca con una nuova macchina HPLC e un aggiornamento del campionatore automatico a loop variabile per migliorare l'attrezzatura per la coltivazione dei funghi e la ricerca genetica.
Hypha Labs (OTCQB:FUNI), una empresa especializada en ciencias de hongos funcionales, ha presentado tres nuevas patentes ante la USPTO para proteger sus innovaciones en el cultivo de hongos. Las patentes incluyen: 1) un Sistema Acelerador de Hongos para el cultivo de micelio utilizando IA y monitoreo en la nube, 2) un Sistema Acelerador Comercial de Hongos para producción a gran escala con cartuchos modulares, y 3) un Sistema de Cartuchos Estériles Reemplazables con procesos de crecimiento optimizados por IA. La empresa busca implementar un modelo de negocio tipo máquina de afeitar y cuchillas a través de su sistema de cartuchos, dirigido tanto a usuarios domésticos como a cocinas comerciales.
Además, la empresa ha mejorado sus capacidades de investigación con una nueva máquina HPLC y una actualización del muestreador automático de bucle variable para avanzar en el equipo de cultivo de hongos y la investigación genética.
Hypha Labs (OTCQB:FUNI)는 기능성 버섯 과학 회사로서, 버섯 재배 혁신을 보호하기 위해 USPTO에 세 가지 새로운 특허를 출원했습니다. 특허에는 1) AI와 클라우드 기반 모니터링을 활용한 버섯 가속 시스템, 2) 모듈식 카트리지를 사용하는 대규모 생산용 상업용 버섯 가속 시스템, 3) AI 최적화 성장 프로세스를 갖춘 교체 가능한 무균 카트리지 시스템이 포함됩니다. 회사는 카트리지 시스템을 통해 면도기와 면도날 비즈니스 모델을 구현하여 가정 사용자와 상업용 주방 모두를 대상으로 하고자 합니다.
또한, 버섯 재배 장비와 유전자 연구를 발전시키기 위해 새로운 HPLC 기계와 가변 루프 자동 시료 추출기 업그레이드를 통해 연구 역량을 강화했습니다.
Hypha Labs (OTCQB:FUNI), une entreprise spécialisée dans les sciences des champignons fonctionnels, a déposé trois nouveaux brevets auprès de l’USPTO pour protéger ses innovations en matière de culture de champignons. Les brevets incluent : 1) un Système d’Accélération de Champignons pour la culture du mycélium utilisant l’IA et la surveillance cloud, 2) un Système d’Accélération Commercial de Champignons pour la production à grande échelle avec des cartouches modulaires, et 3) un Système de Cartouches Stériles Remplaçables intégrant des processus de croissance optimisés par IA. L’entreprise vise à mettre en œuvre un modèle économique de type rasoir/lames via son système de cartouches, ciblant à la fois les utilisateurs domestiques et les cuisines commerciales.
Par ailleurs, l’entreprise a renforcé ses capacités de recherche grâce à une nouvelle machine HPLC et une mise à niveau de l’échantillonneur automatique à boucle variable afin de faire progresser les équipements de culture de champignons et la recherche génétique.
Hypha Labs (OTCQB:FUNI), ein Unternehmen für funktionelle Pilzwissenschaften, hat drei neue Patente beim USPTO eingereicht, um seine Innovationen in der Pilzzucht zu schützen. Die Patente umfassen: 1) ein Mushroom Accelerator System für die Myzelzucht mit KI und cloudbasierter Überwachung, 2) ein Kommerzielles Mushroom Accelerator System für die Großproduktion mit modularen Kartuschen und 3) ein Ersetzbares Steriles Kartuschensystem mit KI-optimierten Wachstumsprozessen. Das Unternehmen verfolgt das Ziel, durch sein Kartuschensystem ein Rasiermesser-/Klingen-Geschäftsmodell umzusetzen, das sowohl Heimnutzer als auch gewerbliche Küchen anspricht.
Darüber hinaus hat das Unternehmen seine Forschungskapazitäten mit einer neuen HPLC-Maschine und einem Upgrade des variablen Loop-Autosamplers erweitert, um die Pilzzuchtgeräte und die genetische Forschung voranzutreiben.
- Patent filings strengthen intellectual property protection for mushroom cultivation technology
- Implementation of recurring revenue model through replaceable cartridge system
- AI and machine learning integration for optimized growth processes
- Expansion into both consumer and commercial markets
- Investment in advanced research equipment (HPLC machine)
- Products not yet launched in the market
- Patents pending approval, not yet granted
LAS VEGAS, NV / ACCESS Newswire / May 13, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of additional patents with the United States Patent and Trade Office (USPTO) which it believes further protects the Company's innovations in the commercialization of a broad array of functional mushroom ingredients for the rapidly growing consumer and enterprise markets.
The three additional patents that have been filed are as follows:
Mushroom Accelerator System for Mycelium Cultivation - This patent focuses on a general mushroom accelerator setup utilizing AI and machine learning to regulate mycelium growth conditions such as temperature, oxygenation, and nutrient levels. It emphasizes cloud-based monitoring and user control via a mobile application.
Commercial Mushroom Accelerator System - This patent is designed for large-scale, high-yield production of mycelium and features modular cartridges, an integrated agitation system, and AI-driven automation. It is more suited for commercial applications rather than small-scale cultivation.
Replaceable Sterile Cartridge System - This patent introduces a specialized cartridge system that can be easily replaced within the Mushroom Accelerator, improving sterility and convenience. It leverages AI and machine learning to optimize growth and extraction processes, with a strong emphasis on maintaining consistent, medicinal-grade output.
"We are blazing an innovative trail, harnessing the magic of the mushroom and bringing it everywhere from the comfort of the home to commercial kitchens who want predictable, scalable mushroom ingredients in their offering," stated Stone Douglass, CEO, Hypha Labs. "These patents, which we have briefly detailed herein, affirm our strong position in the space as we look to our product roll-out on the not-so-far horizon, protecting our mass production plans, A.I. integrations, and maybe most importantly our Replaceable Sterile Cartridge System which to the keen eye should make clear our evergreen relationship with the customer vis-à-vis the razor/razor blade model fully in play."
Hypha Labs remains committed to advancing the science of mushroom cultivation equipment and genetic research to accommodate these advances. The integration of its new HPLC machine and the variable loop autosampler upgrade marks a significant milestone in Hypha's journey to deliver innovative solutions and insights to our customers, clients and partners.
About Hypha Labs, Inc.
The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD LOOKING STATEMENTS:
This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity MediaInc.
(888) 216-3595
team@integritymedia.com
SOURCE: Hypha Labs, Inc.
View the original press release on ACCESS Newswire
FAQ
What patents did Hypha Labs (FUNI) file in May 2025?
How does Hypha Labs' mushroom accelerator technology work?
What is Hypha Labs' (FUNI) business model for their mushroom technology?
What markets is Hypha Labs targeting with their mushroom technology?
What research equipment has Hypha Labs recently acquired?
